Lobbying

340B Working Table's latest lobbying report covers Q2 2026, at $120K. The four quarters Q4 2025–Q3 2026 total $350K. Its first report covers Q2 2023; the issues it reports most are Health Issues.

340B Working Table

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$350K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2023
The first quarter a report named it

Lobbying by quarter

340B Working Table lobbying by quarter
340B Working Table lobbying by quarter
QuarterAmountReports
Q2 2023$10K1
Q3 2023$110K1
Q4 2023$20K1
Q1 2024$80K1
Q2 2024$110K1
Q3 2024$120K1
Q4 2024$50K1
Q1 2025$40K1
Q2 2025$80K1
Q3 2025$70K1
Q4 2025$140K1
Q1 2026$90K1
Q2 2026$120K1
Q3 2026$00

By issue

  • Health issues$1M · 13 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE13 reports

Firms it paid

Firm
Leavitt Partners$1M13 quarters

Former officials lobbying for it

Former position
JOSH TRENTChief Health Counsel for Chairman - House E&C Committee (E&C); Deputy Chief Health Counsel - E&C; Professional Staff - E&C; Health Care Policy Advisor - Senate; Deputy Director Office of Refugee Resettlement HHS; WH Office of Presidential PersonnelQ2 2026
ROBERT CLAYTON ALSPACHChief Health Counsel for Chairman - House E&C Committee (E&C);Counsel - E&C, Clerk - E&C, and Paid Intern - E&CQ3 2024

Lobbying reports

Filed by
07/15for Q2Leavitt Partners$120K
04/20for Q1Leavitt Partners$90K
01/09for Q4 2025Leavitt Partners$140K
25/10/20for Q3 2025Leavitt Partners$70K
25/07/15for Q2 2025Leavitt Partners$80K
25/04/22for Q1 2025Leavitt Partners$40K
25/01/15for Q4 2024Leavitt Partners$50K
24/10/16for Q3 2024Leavitt Partners$120K
24/07/22for Q2 2024Leavitt Partners$110K
24/04/16for Q1 2024Leavitt Partners$80K
24/01/11for Q4 2023Leavitt Partners$20K
23/10/20for Q3 2023Leavitt Partners$110K
23/07/19for Q2 2023Leavitt Partners$10K
23/07/07for Q2 2023Leavitt PartnersUnder $5,000